These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 4789210)

  • 1. [Lead metabolism in the body of schizophrenic patients].
    Soroka VR; Arsent'ev VIa
    Sov Med; 1973 Oct; 36(10):153. PubMed ID: 4789210
    [No Abstract]   [Full Text] [Related]  

  • 2. [Nickel metabolism in schizophrenia patients].
    Soroka VR; Arsent'ev VIa; Mukhaev MS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972 Jan; 72(1):69-72. PubMed ID: 5020157
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chromium, aluminum and silver in the bodies of patients with schizophrenia].
    Arsent'ev VIa; Soroka VR; Mukhaev MS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(1):105-10. PubMed ID: 4747497
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of chronic increased lead absorption on the nervous system--a review article.
    Baloh RW
    Bull Los Angeles Neurol Soc; 1973 Apr; 38(2):91-9. PubMed ID: 4573969
    [No Abstract]   [Full Text] [Related]  

  • 5. Protein levels in schizophrenic patients.
    Assael MI; Braier HR; Bercovits R
    Isr Ann Psychiatr Relat Discip; 1968 Sep; 6(1):85-8. PubMed ID: 5254599
    [No Abstract]   [Full Text] [Related]  

  • 6. [On the concentration of neuraminic acid in the serum and cerebrospinal fluid of patients with schizophrenia].
    Mikhaĭlova KM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(1):102-7. PubMed ID: 5771477
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolism and determination of lead in lead poisoning.
    Matsumoto H
    Rinsho Byori; 1971 Jan; 19(1):56-62. PubMed ID: 5103832
    [No Abstract]   [Full Text] [Related]  

  • 8. Pinoline, a beta-carboline derivative in the serum and cerebrospinal fluid of patients with schizophrenia.
    Rimón R; Airaksinen MM; Kari I; Gynther J; Venäläinen E; Heikkilä L; Ryyppö J; Palo J
    Ann Clin Res; 1984; 16(3):171-5. PubMed ID: 6476781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study of the cerebrospinal fluid-blood-barrier with help of RISA-I-131 in schizophrenics].
    Skalicková O; Dejmal V; Musil J
    Schweiz Arch Neurol Neurochir Psychiatr; 1968; 102(1):213-22. PubMed ID: 5686572
    [No Abstract]   [Full Text] [Related]  

  • 10. Oxidative/nitrative modifications of plasma proteins and thiols from patients with schizophrenia.
    Dietrich-Muszalska A; Olas B; Głowacki R; Bald E
    Neuropsychobiology; 2009; 59(1):1-7. PubMed ID: 19221441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Complex biochemical studies in patients with chronic schizophrenia].
    Slowik S
    Folia Med Cracov; 1968; 10(2):291-373. PubMed ID: 5654386
    [No Abstract]   [Full Text] [Related]  

  • 12. Methionine and tryptophan loading in schizophrenic patients receiving a MAO inhibitor: correlation of behavioral and biochemical changes.
    Spaide J; Neveln L; Tolentino J; Himwich HE
    Biol Psychiatry; 1969 Jul; 1(3):227-33. PubMed ID: 5352654
    [No Abstract]   [Full Text] [Related]  

  • 13. [Some aspects of phosphorus metabolism in schizophrenic patients].
    Milosavljević P; Ilić V; Kalicanin P; Bukelić J
    Neuropsihijatrija; 1969; 17(1):1-9. PubMed ID: 5198672
    [No Abstract]   [Full Text] [Related]  

  • 14. Dysregulation of retinoid transporters expression in body fluids of schizophrenia patients.
    Wan C; Yang Y; Li H; La Y; Zhu H; Jiang L; Chen Y; Feng G; He L
    J Proteome Res; 2006 Nov; 5(11):3213-6. PubMed ID: 17081074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunoelectrophoretic studies of the proteins of serum and cerebrospinal fluid of schizophrenic patients].
    Persić N; Arko K
    Neuropsihijatrija; 1966; 14(1):59-65. PubMed ID: 5191199
    [No Abstract]   [Full Text] [Related]  

  • 16. Oxidative stress in blood platelets from schizophrenic patients.
    Dietrich-Muszalska A; Olas B; Rabe-Jablonska J
    Platelets; 2005 Nov; 16(7):386-91. PubMed ID: 16236599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Methylation of nicotinamide in schizophrenia].
    Sisinni S
    Resen Clin Cient; 1971; 40(7):159-66. PubMed ID: 4255561
    [No Abstract]   [Full Text] [Related]  

  • 18. Toxic trace metals in the mentally ill patients.
    Stanley PC; Wakwe VC
    Niger Postgrad Med J; 2002 Dec; 9(4):199-204. PubMed ID: 12690679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Severe chronic lead insult that maintains body burdens of lead related to those in the skeleton": observations by Dr. Clair Patterson conclusively demonstrated.
    Rosen JF; Pounds JG
    Environ Res; 1998 Aug; 78(2):140-51. PubMed ID: 9719618
    [No Abstract]   [Full Text] [Related]  

  • 20. [Modification of urinary catecholamines induced by drugs in schizophrenic patients].
    Ranzato FP
    Acta Neurol (Napoli); 1965; 20(6):675-83. PubMed ID: 5893528
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.